Article Text

Download PDFPDF
Time to end the routine testing of growth hormone and cortisol on hypoglycaemia screens?
  1. C J Elder1,
  2. V J Wright2,
  3. N P Wright1
  1. 1
    Sheffield Children’s Hospital, Sheffield, UK
  2. 2
    School of Medicine, Sheffield University, Sheffield, UK
  1. Correspondence to Dr N Wright, Sheffield Children’s Hospital, Western Bank, Sheffield S10 2NP, UK; N.P.Wright{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We prospectively studied 124 consecutive hypoglycaemia screens performed on children attending our emergency department over a 27-month period (March 2006 to May 2008). In keeping with most other paediatric services in the UK, we routinely collect a number of samples to permit investigation of low blood sugar, including metabolic investigations, and a random cortisol and growth hormone. Most of these patients have an intercurrent illness and are subsequently thought to have had an episode of “physiological hypoglycaemia”. There is a paucity of published data examining how cortisol and growth hormone respond to hypoglycaemia and no previous work looking at …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; not externally peer reviewed.